Michael Pantze
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 5
- Drug Transport and Resistance Mechanisms 4
- Colorectal Cancer Treatments and Studies 2
-
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Christoph Funk (3 shared papers)Bert L. Lum (3 shared papers)Ashok Rakhit (3 shared papers)Marta Hamilton (3 shared papers)Jie Ling (2 shared papers)Kim A. Johnson (1 shared paper)Chandra Prakash (1 shared paper)Zhuang Miao (1 shared paper)
- Journals
- Molecular Pharmacology (2 papers)International Archives of Allergy and Immunology (1 paper)Anti-Cancer Drugs (1 paper)Drug Metabolism and Disposition (1 paper)European Journal of Clinical Pharmacology (1 paper)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Michael Pantze
7 papers receiving 568 citations
Peers
Comparison fields: 5 of 62
- Pharmacology 188
- Oncology 361
- Pediatrics, Perinatology and Child Health 102
- Hepatology 27
- Pulmonary and Respiratory Medicine 108
Countries citing papers authored by Michael Pantze
This map shows the geographic impact of Michael Pantze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pantze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pantze more than expected).
Fields of papers citing papers by Michael Pantze
This network shows the impact of papers produced by Michael Pantze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pantze. The network helps show where Michael Pantze may publish in the future.
Co-authors
The 21 scholars most cited alongside Michael Pantze, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 218 | |
| 2 | 2005 | 189 | |
| 3 | 2007 | 111 | |
| 4 | 2001 | 35 | |
| 5 | 2009 | 17 | |
| 6 | 2014 | 12 | |
| 7 | 2010 | 6 |
About Michael Pantze
Michael Pantze is a scholar working on Oncology, Epidemiology, Surgery, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 7 papers that have together received 588 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Liver Disease Diagnosis and Treatment (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Fatty Acid Research and Health (1 paper), Cholesterol and Lipid Metabolism (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Pharmacology (188 citations), Oncology (361 citations), Pediatrics, Perinatology and Child Health (102 citations), Hepatology (27 citations) and Pulmonary and Respiratory Medicine (108 citations). Michael Pantze has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Christoph Funk, Bert L. Lum, Ashok Rakhit, Marta Hamilton, Jie Ling, Kim A. Johnson, Chandra Prakash, Zhuang Miao, Scott Fettner and Myriam Riek. Their work appears in journals such as Molecular Pharmacology, International Archives of Allergy and Immunology, Anti-Cancer Drugs, Drug Metabolism and Disposition and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.